{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-017198","form_type":"8-K","ticker":"TVGN","cik":"0001860871","company_name":"Tevogen Bio Holdings Inc.","filed_at":"2025-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.226179+00:00","generated_at":"2026-05-18T14:43:56.446880+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"CEO Ryan Saadi contributes $500,000 to Tevogen Bio for new HQ costs","bullets":["Founder and CEO Ryan Saadi contributed $500,000 cash to Tevogen Bio on June 30, 2025.","Contribution earmarked for build-out and first-year operating costs of new Warren, NJ headquarters.","CEO personally funding corporate infrastructure expansion, signaling insider commitment."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-017198","json":"https://secwatch.observer/filing/0001641172-25-017198.json","markdown":"https://secwatch.observer/filing/0001641172-25-017198.md","text":"https://secwatch.observer/filing/0001641172-25-017198.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860871/000164117225017198/0001641172-25-017198-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860871/000164117225017198/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T14:43:56.446880+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}